Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

BIOLASE Inc

BIOL
Current price
0.007 USD -0.0085 USD (-54.84%)
Last closed 0.0045 USD
ISIN US0909112072
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 439 165 USD
Yield for 12 month -99.58 %
1Y
3Y
5Y
10Y
15Y
BIOL
21.11.2021 - 28.11.2021

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California. On October 1, 2024, BIOLASE, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. Address: 27042 Towne Centre Drive, Foothill Ranch, CA, United States, 92610-2811

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.2 USD

P/E ratio

0.0007

Dividend Yield

Current Year

+49 164 000 USD

Last Year

+48 462 000 USD

Current Quarter

+11 555 000 USD

Last Quarter

+10 131 000 USD

Current Year

+16 724 001 USD

Last Year

+15 911 000 USD

Current Quarter

+4 609 000 USD

Last Quarter

+3 336 000 USD

Key Figures BIOL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -13 183 000 USD
Operating Margin TTM -27.87 %
PE Ratio 0.0007
Return On Assets TTM -27.96 %
PEG Ratio -0.22
Return On Equity TTM -736.26 %
Wall Street Target Price 1.2 USD
Revenue TTM 46 098 000 USD
Book Value -0.13 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -19.1 %
Dividend Yield
Gross Profit TTM 16 529 000 USD
Earnings per share 16.18 USD
Diluted Eps TTM 16.18 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -41.65 %

Dividend Analytics BIOL

Dividend growth over 5 years

Continuous growth

1 year

Payout Ratio 5 years average

Dividend History BIOL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 24.06.2005
Forward Annual Dividend Yield
Last Split Factor 1:100
Payout Ratio
Last Split Date 28.07.2023
Dividend Date 11.05.2018

Stock Valuation BIOL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 0.0007
Forward PE
Enterprise Value Revenue 0.2101
Price Sales TTM 0.0095
Enterprise Value EBITDA -0.7143
Price Book MRQ 0.7658

Financials BIOL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BIOL

For 52 weeks

0.008 USD 1.88 USD
50 Day MA 0.048 USD
Shares Short Prior Month 1 668 804
200 Day MA 0.2 USD
Short Ratio 1.09
Shares Short 2 098 747
Short Percent 5 %